Regeneron Pharmaceuticals total depreciation and amortization - cash flow for the twelve months ending March 31, 2025 was $1.201B, a 14.86% increase year-over-year.
Regeneron Pharmaceuticals annual total depreciation and amortization - cash flow for 2024 was $0.483B, a 14.7% increase from 2023.
Regeneron Pharmaceuticals annual total depreciation and amortization - cash flow for 2023 was $0.421B, a 23.32% increase from 2022.
Regeneron Pharmaceuticals annual total depreciation and amortization - cash flow for 2022 was $0.341B, a 19.29% increase from 2021.
Regeneron Pharmaceuticals Total Depreciation and Amortization - Cash Flow 2010-2025 | REGN